| # | Title | Journal | Year | Citations |
|---|
| 1 | Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors | Journal of Virology | 2011 | 393 |
| 2 | Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response | Vaccine | 2021 | 111 |
| 3 | Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies | Nature Chemical Biology | 2013 | 106 |
| 4 | Vaccination induces HIV broadly neutralizing antibody precursors in humans | Science | 2022 | 71 |
| 5 | Creating an African HIV Clinical Research and Prevention Trials Network: HIV Prevalence, Incidence and Transmission | PLoS ONE | 2015 | 43 |
| 6 | A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults | PLoS ONE | 2015 | 31 |
| 7 | Structural basis of broad HIV neutralization by a vaccine-induced cow antibody | Science Advances | 2020 | 31 |
| 8 | Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression | Journal of Experimental Medicine | 2016 | 30 |
| 9 | Structural informatics, modeling, and design with an open‐source Molecular Software Library (MSL) | Journal of Computational Chemistry | 2012 | 23 |
| 10 | A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates | Nature Communications | 2023 | 21 |
| 11 | A Phase 1 Human Immunodeficiency Virus Vaccine Trial for Cross-Profiling the Kinetics of Serum and Mucosal Antibody Responses to CN54gp140 Modulated by Two Homologous Prime-Boost Vaccine Regimens | Frontiers in Immunology | 2017 | 20 |
| 12 | Moral injury in the wake of coronavirus: Attending to the psychological impact of the pandemic. | Psychological Trauma: Theory, Research, Practice, and Policy | 2020 | 18 |
| 13 | Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools | Biotechnology and Bioengineering | 2022 | 18 |
| 14 | Identifying the immune interactions underlying HLA class I disease associations | ELife | 2020 | 17 |
| 15 | Oral pre‐exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study | Journal of the International AIDS Society | 2022 | 15 |
| 16 | Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults | PLoS ONE | 2014 | 13 |
| 17 | Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya | PLoS ONE | 2020 | 11 |
| 18 | Cohort Profile: IAVI’s HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery | International Journal of Epidemiology | 2021 | 11 |
| 19 | Must there be a “war” against coronavirus? | Indian Journal of Medical Ethics | 2020 | 11 |
| 20 | Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on ‘Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines’, 31 January–2 February 2006, IAVI, New York, USA | Aids | 2007 | 10 |
| 21 | Components of antenatal care received by women in fishing communities on Lake Victoria, Uganda; a cross sectional survey | BMC Health Services Research | 2020 | 9 |
| 22 | The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development | Tuberculosis | 2021 | 9 |
| 23 | Long-term follow-up of study participants from prophylactic HIV vaccine clinical trials in Africa | Human Vaccines and Immunotherapeutics | 2014 | 8 |
| 24 | Infection with multiple HIV-1 founder variants is associated with lower viral replicative capacity, faster CD4+ T cell decline and increased immune activation during acute infection | PLoS Pathogens | 2020 | 8 |
| 25 | Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration | Antibodies | 2020 | 7 |
| 26 | Barriers and Facilitators of Family Planning Use in Fishing Communities of Lake Victoria in Uganda | Journal of Primary Care and Community Health | 2020 | 7 |
| 27 | Prevalence and correlates of HIV infection among adolescents and young people living in fishing populations along Lake Victoria Fishing Communities in Uganda | Pan African Medical Journal | 2020 | 7 |
| 28 | A Trial of M72/AS01E Vaccine to Prevent Tuberculosis | New England Journal of Medicine | 2020 | 6 |
| 29 | Genital Abnormalities, Hormonal Contraception, and Human Immunodeficiency Virus Transmission Risk in Rwandan Serodifferent Couples | Journal of Infectious Diseases | 2021 | 6 |
| 30 | Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set | PLoS ONE | 2021 | 6 |
| 31 | Correlates of knowledge of family planning among people living in fishing communities of Lake Victoria, Uganda | BMC Public Health | 2020 | 5 |
| 32 | A Stronger Innate Immune Response During Hyperacute Human Immunodeficiency Virus Type 1 (HIV-1) Infection Is Associated With Acute Retroviral Syndrome | Clinical Infectious Diseases | 2021 | 5 |
| 33 | Utilizing Computational Machine Learning Tools to Understand Immunogenic Breadth in the Context of a CD8 T-Cell Mediated HIV Response | Frontiers in Immunology | 2021 | 5 |
| 34 | Use of propensity score matching to create counterfactual group to assess potential HIV prevention interventions | Scientific Reports | 2021 | 5 |
| 35 | Phylogenetic Networks and Parameters Inferred from HIV Nucleotide Sequences of High-Risk and General Population Groups in Uganda: Implications for Epidemic Control | Viruses | 2021 | 5 |
| 36 | Low awareness of oral and injectable PrEP among high-risk adolescent girls and young women in Kampala, Uganda | BMC Infectious Diseases | 2022 | 5 |
| 37 | OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial | Retrovirology | 2009 | 4 |
| 38 | Sampling SARS-CoV-2 Proteomes for Predicted CD8 T-Cell Epitopes as a Tool for Understanding Immunogenic Breadth and Rational Vaccine Design | Frontiers in Bioinformatics | 2021 | 4 |
| 39 | A Novel Sample Selection Approach to Aid the Identification of Factors That Correlate With the Control of HIV-1 Infection | Frontiers in Immunology | 2021 | 4 |
| 40 | Evolution of Condom Use Among a 5-Year Cohort of Female Sex Workers in Zambia | AIDS and Behavior | 2022 | 4 |
| 41 | HIV vaccines in 2022: where to from here? | Journal of the International AIDS Society | 2022 | 4 |
| 42 | Relative efficiency of demand creation strategies to increase voluntary medical male circumcision uptake: a study conducted as part of a randomised controlled trial in Zimbabwe | BMJ Global Health | 2021 | 3 |
| 43 | PROTOCOL: Social and behaviour change communication interventions for strengthening HIV prevention and research among adolescent girls and young women in low‐ and middle‐income countries: An evidence and gap map | Campbell Systematic Reviews | 2022 | 3 |
| 44 | Nonhuman Primates Are Protected against Marburg Virus Disease by Vaccination with a Vesicular Stomatitis Virus Vector-Based Vaccine Prepared under Conditions to Allow Advancement to Human Clinical Trials | Vaccines | 2022 | 3 |
| 45 | Infectious Disease Modelling of HIV Prevention Interventions: A Systematic Review and Narrative Synthesis of Compartmental Models | Pharmacoeconomics | 2023 | 3 |
| 46 | S021-06 OA. Potent and broad neutralizing antibodies from HIV-1 non-clade B infected donor reveal a new HIV-1 vaccine target | Retrovirology | 2009 | 2 |
| 47 | Major Negative Social Impacts Are Rare in Phase 1 HIV Vaccine Trials in Africa | AIDS Research and Human Retroviruses | 2014 | 2 |
| 48 | Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study | BMC Public Health | 2020 | 2 |
| 49 | HIV-1 Gag-Pol Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity | Viruses | 2021 | 2 |
| 50 | Uhambo — Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine | New England Journal of Medicine | 2021 | 2 |
